DUX4 and facioscapulohumeral muscular dystrophy: Notably, Balog et al. 2012 investigated the correlation between the epigenetic status of the DUX4 promoter with clinical severity and muscle impairment in fibroblasts and myoblasts derived from 15 FSHD patients.